2018年《肝硬化肝性脑病诊疗指南》更新要点解读  

Updated key points of Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis( 2018)

作　　者：李小科[1] 王姗 李志国[1] 甘大楠[1] 叶永安[1] LI Xiaoke;WANG Shan;LI Zhiguo(Department of Gastroenterology,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine & Institute of Liver Diseases,Beijing University of Chinese Medicine,Beijing 100700,China)

机构地区：[1]北京中医药大学东直门医院消化科北京中医药大学肝病研究所

出　　处：《临床肝胆病杂志》2019年第7期1485-1488,共4页Journal of Clinical Hepatology

基　　金：北京中医药大学东直门医院“111”协同创新院际合作项目(2016-DZM111-JC016);北京中医药大学科研创新团队项目(2019-JYB-TD-009)

摘　　要：2018年中华医学会肝病学分会发布了《肝硬化肝性脑病诊疗指南》,为肝性脑病包括轻微型肝性脑病的临床诊断和治疗提出推荐性意见,具有重要的指导意义。与2013年中国《肝性脑病诊治共识意见(2013年,重庆)》、2014年美国肝脏病学会与欧洲肝脏病学会颁布的《2014年AASLD/EASL慢性肝病肝性脑病实践指南》相比,新版指南在肝性脑病的分级、诊断、治疗等方面有较多更新亮点。归纳了此指南的更新要点,以期细化理解新版指南对临床治疗的指导作用,提高诊疗水平。In 2018, Chinese Society of Hepatology, Chinese Medical Association, issued Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis, which gives recommendations for the clinical diagnosis and treatment of hepatic encephalopathy including minimal hepatic encephalopathy and has important guiding significance. Compared with Consensus on the diagnosis and treatment of hepatic encephalopathy in China (Chongqing, 2013) and Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver, the updated guidelines have several new points in the classification, diagnosis, and treatment of hepatic encephalopathy. This article summarizes the updated key points in the guidelines, so as to understand the effect of the guidelines in guiding clinical treatment and improve diagnosis and treatment.

关 键 词：肝性脑病 诊断 治疗学 诊疗准则(主题) 

分 类 号：R575.2[医药卫生—消化系统]